WeSearch

Mango founder’s son steps down as vice-chair amid probe into father’s death

3 sources covered this ⚠ Left-only compare →
Coverage diverges in the emphasis placed on the allegations against Jonathan Andic. The Guardian highlights his resignation as a proactive measure to address the allegations, framing it as a fight against the claims made against him. In…
·2 min read · 0 reactions · 0 comments · 9 views
#fashion#crime#spain
Mango founder’s son steps down as vice-chair amid probe into father’s death
⚡ TL;DR · AI summary

Jonathan Andic, son of Mango founder Isak Andic, has stepped down as vice-chair amid an investigation into his father's death. He asserts his innocence and cites the need to focus on his legal defense as the reason for his temporary resignation. The investigation suggests that Isak's death may not have been accidental, with Jonathan allegedly playing a significant role.

Key facts
Original article
Straits Times — World
Read full at Straits Times — World →
Opening excerpt (first ~120 words) tap to expand

Mango founder’s son steps down as vice-chair amid probe into father’s deathSign up now: Get ST's newsletters delivered to your inboxPolice officers escort Mr Jonathan Andic, son of Mango fashion chain founder Isak Andic, as he arrives at a court near Barcelona. PHOTO: AFPPublished May 26, 2026, 07:15 PMUpdated May 26, 2026, 07:15 PMMADRID – Mr Jonathan Andic, son of Mango founder Isak Andic, said on May 26 he was stepping down “momentarily” as the fashion group’s vice-chair after being named a suspect in a probe into his father’s death, while strongly asserting his innocence.“The attention and focus that my defence in the judicial process currently requires do not allow me to maintain the high level of commitment demanded by my role at the company,” Mr Andic said in a letter in Spanish…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Straits Times — World.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments